Characteristics and Sequelae of Paregoric Abuse
1966; American College of Physicians; Volume: 65; Issue: 5 Linguagem: Inglês
10.7326/0003-4819-65-5-1019
ISSN1539-3704
Autores Tópico(s)Respiratory and Cough-Related Research
ResumoArticle1 November 1966Characteristics and Sequelae of Paregoric AbuseA. MARTIN LERNER, M.D., F.A.C.P., FREDERICK J. OERTHER, M.D.A. MARTIN LERNER, M.D., F.A.C.P.Search for more papers by this author, FREDERICK J. OERTHER, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-65-5-1019 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptIn 1955, records of the Narcotics Bureau in Detroit showed that no one among 1,267 persons arrested for the illicit use of drugs abused paregoric. During the next 8 years paregoric was used increasingly in Detroit as an opium or heroin substitute. At the zenith (1963) of its use as a narcotic in this period, paregoric claimed 713 of 994 narcotics users. Since at present this medical oddity is again virtually extinct, this report is largely a historical resumé of an unusual, and hopefully singular, experience.MEDICAL USE OF PAREGORICIn the early eighteenth century LeMort, the chemistry profesor at...References1. GOODMANGILMAN LSA: The Pharmacological Basis of Therapeutics, 3rd ed. The Macmillan Co., New York, 1965, pp. 247-284. Google Scholar2. LEWISZINBERC DCNE: Narcotic usage. II. A historical perspective on a difficult medical problem. New Eng. J. Med. 270: 1045, 1964. CrossrefMedlineGoogle Scholar3. DEKE AL: H.M. Chief Inspector, Dangerous Drugs, London, England—June 5, 1964 (personal communication). Google Scholar4. : Remarks of Douglas Dillon, Secretary of Treasury, at White House Conference on Narcotic and Drug Abuse, Washington, D. C., September 27, 1962. U. S. Government Printing Office, Washington, D. C., 1962. Google Scholar5. CURRAN WJ: Narcotics, treatment and crime (law and medicine notes). New Eng. J. Med. 271, 309, 1964. Google Scholar6. CURRAN WJ: Massachusetts drug addiction act: legislative history and comparative analysis. Harvard J. Legislation 1: 89, 1964. Google Scholar7. Personal communications with narcotics officers of several cities, notably, St. Louis, Mo.; Miami, Fla.; Atlanta, Ga.; New York, N. Y.; and Louisville, Ky. Google Scholar8. ZINBERGLEWIS NEDC: Narcotic usage. I. A spectrum of a difficult medical problem. New Eng. J. Med. 270: 989, 1964. CrossrefMedlineGoogle Scholar9. LERNER AM: Paregoric addiction (letter to the editor). New Eng. J. Med. 274: 1151, 1966. CrossrefGoogle Scholar10. OERTHERGOODMANLERNER FJJLAM: Infections in paregoric addicts. JAMA 190: 683, 1964. CrossrefMedlineGoogle Scholar11. DOANE JC: Tetanus as complication in drug inebriety. JAMA 82: 1105, 1924. CrossrefGoogle Scholar12. LEVINSONMARSKESHEIN ARLMK: Tetanus in heroin addicts. JAMA 157: 658, 1955. CrossrefMedlineGoogle Scholar13. WIKLERWILLIAMSDOUGLASSEMMONSDUNN AEGEDCWRC: Mycotic endocarditis: report of case. JAMA 119: 333, 1942. CrossrefGoogle Scholar14. MOST H: Falciparum malaria among drug addicts: epidemiologic studies. Amer. J. Public Health 30: 403, 1940. CrossrefGoogle Scholar15. WENDTPUROSHAPIROMATHEWSWOLF VEHEJWPL: Angiothrombotic pulmonary hypertension in addicts. "Blue velvet" addiction. JAMA 188: 755, 1964. CrossrefMedlineGoogle Scholar16. STARREDWARDS AML: Mitral replacement: clinical experience with a ball-valve prosthesis. Ann. Surg. 154: 726, 1961. CrossrefMedlineGoogle Scholar17. FINLAND M: Current status of therapy in bacterial endocarditis. JAMA 166: 364, 1958. CrossrefMedlineGoogle Scholar18. SABATHPOSTICFINLAND LDBM: Methicillin treatment of severe staphylococcal disease. Observations in 146 cases. New Eng. J. Med. 267: 1049, 1962. CrossrefMedlineGoogle Scholar19. TYNESFROMMEYER BSWB: Bacteroides septicemia. Cultural, clinical, and therapeutic features in a series of twenty-five patients. Ann. Intern. Med. 56: 12, 1962. LinkGoogle Scholar20. BURTONZAWADSKIWETHERELLMOY JFESHRTW: Mainliners and blue velvet. J. Forensic Sci. 10: 466, 1965. MedlineGoogle Scholar21. O'DRISCOLLLINDLEY WGGR: Self administration of tripelennamine by a narcotic addict. New Eng. J. Med. 257: 376, 1957. CrossrefMedlineGoogle Scholar22. KRAINERBERMANWISHNICK LESD: Parenteral talcum granulomatosis: a complication of narcotic addiction (abstract). Lab. Invest. 11: 671, 1962. Google Scholar23. PUROWOLFSKIRGAUDASVASQUEZ HPLJJ: Experimental production of human blue velvet and red devil lesions. Amer. J. Clin. Path. 44: 571, 1965. Google Scholar24. PUROWOLFSKIRGAUDASVASQUEZ HPLJJ: Experimental production of human "Blue Velvet" and "Red Devil" lesions. JAMA 197: 152, 1966. CrossrefGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: A. MARTIN LERNER, M.D., F.A.C.P.; FREDERICK J. OERTHER, M.D.Affiliations: Detroit, MichiganFrom the Departments of Medicine, Microbiology, and Pathology and the Detroit General Receiving Hospital, Wayne State University School of Medicine, Detroit, Mich.This work was aided by grant 5 T1 AI 261, the U. S. Public Health Service, Washington, D. C.This manuscript appears in part in the autumn number (1966) of the Bulletin on Narcotics published by the European Office of the United Nations, Geneva, Switzerland.Requests for reprints should be addressed to A. Martin Lerner, M.D., Wayne State University School of Medicine, 1400 Chrysler, Detroit, Mich. 48207. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byOpiates and OpioidsAbscesses secondary to parenteral abuse of drugs. A study of demographic and bacteriological characteristics.Pulmonary complications of intravenous drug misuse. 1. Epidemiology and non-infective complications.Management of the oral surgery patient addicted to heroinA protocol for the treatment of severe infections of the handLung and heart pathology in fatal drug addiction. A consecutive autopsy studyRole of echocardiography in suspected infective endocarditis in intravenous drug abusersTenosynovitis in drug addictsEffects of the combination of tripelennamine and Pentazocine at the behavioral and molecular levelsSurgical infections in drug addictsCurrent Trends in the Abuse of Pentazocine and Tripelennamine: The Metropolitan St. Louis ExperiencePulmonary hypertension and foreign body granulomas in intravenous drug abusersPulmonary Function Studies in Ex-Heroin UsersExtremity complications of drug abuseSepticemia in Narcotic AddictsPulmonary and Cardiovascular Implications of Drug AddictionPhysical and Mental Pathology Due to Drug AddictionPseudoheroinismDrugs of abuse: Legal and illegalDermatopathology of narcotic addictionForeign Particle Embolism in Drug Addicts: Respiratory PathophysiologyF. G. DOUGLAS, M.D., K. J. KAFILMOUT, M.B., Ch.B., N. L. PATT, M.D.Pulmonary Angiothrombosis Caused by "Blue Velvet" AddictionJAMES J. SZWED, M.D.Fatal talc embolism in a drug addictThe narcotic addict as a medical patientA Review of the Medical Complications of Narcotic AddictionDermatologic Complications of Heroin AddictionThe Medical Sequelae of Narcotic AddictionCHARLES E. CHERUBIN, M.D. 1 November 1966Volume 65, Issue 5Page: 1019-1030KeywordsEndocarditisGranulomasHepatitis A virusHeroinHospital medicineHypertensionMedical servicesMicrobiologyOpiumSepsis ePublished: 1 December 2008 Issue Published: 1 November 1966 PDF downloadLoading ...
Referência(s)